Envoy Medical Inc. (COCH)
COCH trades on Nasdaq in Health Care, Industrial Specialties. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:Revenues), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1840877/000121390026032683/0001213900-26-032683-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.
Profile
| Field | Value |
|---|---|
| Ticker | COCH on Nasdaq |
| Sector | Health Care |
| Industry | Industrial Specialties |
| Country | United States |
| IPO year | 2021 |
| SEC CIK | 0001840877 |
| SEC industry code | Orthopedic, Prosthetic & Surgical Appliances & Supplies |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $241K |
| Net income | -$23.8M |
| Operating income | -$22.3M |
| Net margin | -9857.3% |
| Operating margin | -9240.7% |
| Revenue growth | +7.1% |
| Cash | $3.7M |
| Total assets | $8.6M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 222.4× |
Warning signs
| Sign | Finding | Source |
|---|---|---|
| Going concern | States substantial doubt about continuing as a going concern. "These matters raise substantial doubt about our ability to continue as a going concern." | 10-Q 2026-11-05 |
| Cash and burn | $14.6M cash; operating cash flow -$5.6M a quarter. | Report 2026-09-30 |
| Shares outstanding | 7,744,488 (2026-11-05); 28,786,511 a year earlier; 19,549,982 three years earlier. 1y figure adjusted for split (1-for-10 overall); 3y figure adjusted for split (1-for-10 overall). | Cover page 2026-11-05 |
| Reverse splits, 3 years | 1; latest 1-for-10 on 2026-10-26 | Source 2026-10-26 |
| Shelf and offerings, 12 months | 0 S-3/F-3 shelf filings; 0 424B5 takedowns | None on EDGAR |
| Exchange deficiency notices, 12 months | 2 (8-K item 3.01) | 8-K 2026-05-22 |
| Auditor | Grant Thornton LLP, Ft. Lauderdale, Florida, United States; changed auditors 1 time in 24 months | 8-K 4.01 2026-03-31 |
| Late filings, 12 months | None | None on EDGAR |
| Insider trades, 12 months | Bought $673K, sold $0 on the open market | SEC Forms 3/4/5 data sets 2026-09-30 |
From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.
Quarterly results
| Quarter | Revenue | Net income | Op. cash flow | Cash | Total debt | TTM revenue | Source |
|---|---|---|---|---|---|---|---|
| Q3 2026 2026-09-30 | $66K | -$3.9M | -$5.0M | $14.6M | No debt tags | $231K | 10-Q 2026-11-05 |
| Q2 2026 2026-06-30 | $51K | -$6.0M | -$5.5M | $19.7M | No debt tags | $207K | 10-Q 2026-08-10 |
| Q1 2026 2026-03-31 | $39K | -$4.4M | -$6.1M | $25.3M | No debt tags | $234K | 10-Q 2026-05-11 |
| Q4 2025 2025-12-31 | $75K | -$6.6M | -$5.7M | $3.7M | No debt tags | $241K | 10-K 2026-03-23 |
| Q3 2025 2025-09-30 | $42K | -$6.5M | -$4.3M | $3.6M | No debt tags | $208K | 10-Q 2026-11-05 |
| Q2 2025 2025-06-30 | $78K | -$5.7M | -$4.5M | $5.3M | No debt tags | $222K | 10-Q 2026-08-10 |
| Q1 2025 2025-03-31 | $46K | -$5.0M | -$3.7M | $5.3M | No debt tags | $212K | 10-Q 2026-05-11 |
| Q4 2024 2024-12-31 | $42K | -$4.6M | -$5.1M | $5.5M | $9.3M | $225K | 10-K 2026-03-23 |
From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-1 | POS AM | 2026-06-12 |
| Latest annual report AMENDMENT NO. 1 TO FORM 10-K | 10-K/A | 2026-04-13 |
| Latest quarterly / interim QUARTERLY REPORT | 10-Q | 2026-11-05 |
| Latest current report CURRENT REPORT | 8-K | 2026-11-05 |
| Latest proxy DEFINITIVE ADDITIONAL MATERIALS | DEFA14A | 2026-09-02 |
Source: SEC EDGAR submissions feed, 330 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | -5.8% |
| 1 month | +2.2% |
| 3 months | -9.7% |
| Year to date | +1.9% |
| 1 year | +1.4% |
| From 52-week high | -25.2% |
Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.
Other listings for this company
| Ticker | Name | Price |
|---|---|---|
| COCHW | Envoy Medical Inc Warrant | $0.0260 |
Peers in Industrial Specialties
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| YDDL | One and One Green Technologies. Inc | $1.00 | -1.96% | $56.0M |
| WBX | Wallbox N.V. | $1.95 | -8.02% | $46.6M |
| APT | Alpha Pro Tech Ltd. | $6.43 | +4.05% | $66.0M |
| CNXU | Conexeu Sciences Inc. | $2.21 | +1.38% | $67.0M |
| MYO | Myomo Inc. | $1.02 | -17.07% | $40.9M |
| NTRB | Nutriband Inc. | $5.81 | -4.75% | $70.6M |
| NTIC | Northern Technologies International Corporation | $7.65 | -1.03% | $72.6M |
| MAMO | Massimo Group | $0.9301 | -4.59% | $38.7M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier